Washington Capital Management Inc. Sells 1,064 Shares of Leidos Holdings, Inc. (NYSE:LDOS)

Washington Capital Management Inc. decreased its position in shares of Leidos Holdings, Inc. (NYSE:LDOSFree Report) by 27.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,836 shares of the aerospace company’s stock after selling 1,064 shares during the quarter. Washington Capital Management Inc.’s holdings in Leidos were worth $409,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of LDOS. Fiduciary Trust Co boosted its position in shares of Leidos by 36.4% during the third quarter. Fiduciary Trust Co now owns 23,941 shares of the aerospace company’s stock worth $3,902,000 after purchasing an additional 6,395 shares in the last quarter. Atria Investments Inc raised its stake in Leidos by 100.1% during the 3rd quarter. Atria Investments Inc now owns 8,837 shares of the aerospace company’s stock worth $1,440,000 after buying an additional 4,421 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in Leidos by 51.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock worth $136,491,000 after acquiring an additional 283,558 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in Leidos by 21.4% in the third quarter. Los Angeles Capital Management LLC now owns 55,165 shares of the aerospace company’s stock valued at $8,992,000 after acquiring an additional 9,710 shares during the period. Finally, Rockefeller Capital Management L.P. bought a new stake in shares of Leidos in the third quarter worth about $4,622,000. Institutional investors and hedge funds own 76.12% of the company’s stock.

Insider Transactions at Leidos

In other Leidos news, Director Noel B. Geer purchased 2,000 shares of Leidos stock in a transaction that occurred on Wednesday, November 20th. The stock was acquired at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the completion of the acquisition, the director now owns 2,000 shares of the company’s stock, valued at approximately $322,260. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Surya N. Mohapatra sold 2,748 shares of the company’s stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $194.97, for a total value of $535,777.56. Following the completion of the sale, the director now owns 20,001 shares in the company, valued at $3,899,594.97. This represents a 12.08 % decrease in their position. The disclosure for this sale can be found here. 0.96% of the stock is owned by company insiders.

Analysts Set New Price Targets

LDOS has been the topic of several recent analyst reports. Barclays lifted their price objective on Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Truist Financial reduced their price target on shares of Leidos from $205.00 to $185.00 and set a “buy” rating for the company in a report on Friday, November 22nd. Robert W. Baird raised their price objective on shares of Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. JPMorgan Chase & Co. boosted their price objective on shares of Leidos from $175.00 to $185.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Finally, UBS Group assumed coverage on Leidos in a report on Monday, December 2nd. They set a “neutral” rating and a $182.00 target price for the company. Five investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $179.07.

Get Our Latest Stock Report on LDOS

Leidos Stock Down 0.9 %

NYSE:LDOS opened at $140.24 on Thursday. The firm has a market capitalization of $18.71 billion, a price-to-earnings ratio of 15.97, a price-to-earnings-growth ratio of 1.06 and a beta of 0.66. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87. Leidos Holdings, Inc. has a twelve month low of $108.97 and a twelve month high of $202.90. The stock’s 50 day moving average price is $153.40 and its two-hundred day moving average price is $158.32.

Leidos (NYSE:LDOSGet Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.96 by $0.97. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The firm had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.06 billion. During the same period in the prior year, the firm posted $2.03 earnings per share. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. Equities research analysts expect that Leidos Holdings, Inc. will post 10.03 earnings per share for the current fiscal year.

Leidos Company Profile

(Free Report)

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.

Read More

Want to see what other hedge funds are holding LDOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Leidos Holdings, Inc. (NYSE:LDOSFree Report).

Institutional Ownership by Quarter for Leidos (NYSE:LDOS)

Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.